參考文獻 |
1. Geethangili, M. and Y.M. Tzeng, Review of Pharmacological Effects of Antrodia camphorata and its Bioactive Compounds. Evid Based Complement Alternat Med, 2009.
2. Chang, T.T. and W.N. Chou, Antrodia-Cinnamomea Sp-Nov on Cinnamomum-Kanehirai in Taiwan. Mycological Research, 1995. 99: p. 756-758.
3. Chang, T.-T., Basidiomatal formation of Antrodia cinnamomea on artificial agar media. 2005. 46: p. 151-154.
4. Chang, T.-T., Antrodia cinnamomea reconsidered and A. salmonea sp. nov. on Cunninghamia konishii in Taiwan. Bot.Bull.Acad.Sin., 2004. 45: p. 347-352.
5. Wu, s.-H., Antrodia camphorata ("niu-chang-chin"), new combination of a medicinal fungus in Taiwan. Bot.Bull.Acad.Sin., 1997. 38: p. 273-275.
6. Chien, S.C., et al., Anti-inflammatory activities of new succinic and maleic derivatives from the fruiting body of Antrodia camphorata. J Agric Food Chem, 2008. 56(16): p. 7017-22.
7. Shen, Y.C., et al., Evaluation of the anti-inflammatory activity of zhankuic acids isolated from the fruiting bodies of Antrodia camphorata. Planta Med, 2004. 70(4): p. 310-4.
8. Hsieh, Y.H., et al., Antrocamphin A, an anti-inflammatory principal from the fruiting body of Taiwanofungus camphoratus , and its mechanisms. J Agric Food Chem, 2010. 58(5): p. 3153-8.
9. Chen, K.C., et al., Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells. Nutr Cancer, 2007. 57(1): p. 111-21.
10. Peng, C.C., et al., Antrodia camphorata extract induces replicative senescence in superficial TCC, and inhibits the absolute migration capability in invasive bladder carcinoma cells. J Ethnopharmacol, 2007. 109(1): p. 93-103.
11. Nakamura, N., et al., Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line. J Nat Prod, 2004. 67(1): p. 46-8.
12. Yang, H.L., et al., Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett, 2006. 231(2): p. 215-27.
13. Hsieh, Y.C., et al., Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin- and Bax-triggered mitochondrial pathway. Chem Res Toxicol, 2010. 23(7): p. 1256-67.
14. Lin, Y.W., et al., The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells. J Sci Food Agric, 2010. 90(10): p. 1739-44.
15. Hsu, Y.L., et al., Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines. Cancer Lett, 2005. 221(1): p. 77-89.
16. Hsu, Y.L., et al., Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway. Food Chem Toxicol, 2007. 45(7): p. 1249-57.
17. Ho, Y.C., et al., The hepatoprotective activity against ethanol-induced cytotoxicity by aqueous extract of Antrodia cinnamomea. Journal of the Chinese Institute of Chemical Engineers, 2008. 39(5): p. 441-447.
18. Chang, T.-T. and C. WN, Antrodia cinnamomea sp. nov. on Cinnamomum kanehirai in Taiwan. Mycol. Res., 1995. 99: p. 756-758.
19. Chu, Y.C., et al., Fructification of Antrodia cinnamomea was strain dependent in malt extract media and involved specific gene expression. J Agric Food Chem, 2009. 58(1): p. 257-61.
20. Chu, H.W., A study on timber cultivation of Antrodia camphorata. Chaoyang University of Technology, 2005.
21. Lin, T.Y., et al., Metabolite Profiles for Antrodia cinnamomea Fruiting Bodies Harvested at Different Culture Ages and from Different Wood Substrates. Journal of agricultural and food chemistry.
22. Evan GI, B.L., Whyte M, Harrington E, Apoptosis and the cell cycle. Curr Opin Cell Biol, 1995. 7(6): p. 825-834.
23. B.Amati, T.D.L., G.I.Evan, H.Land, The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. The EMBO Journal, 1993. 12: p. 5083-5087.
24. Kaikkonen, M.U., M.T.Y. Lam, and C.K. Glass, Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovascular Research, 2011. 90(3): p. 430.
25. Yi, R., et al., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & development, 2003. 17(24): p. 3011.
26. Bushati, N. and S.M. Cohen, microRNA functions. Annu. Rev. Cell Dev. Biol., 2007. 23: p. 175-205.
27. Catto, J.W.F., et al., MicroRNA in prostate, bladder, and kidney cancer: a systematic review. European urology, 2011. 59(5): p. 671-81.
28. Bartel, D.P., MicroRNAs:: Genomics, Biogenesis, Mechanism, and Function. Cell, 2004. 116(2): p. 281-297.
29. Du, T. and P.D. Zamore, microPrimer: the biogenesis and function of microRNA. Development, 2005. 132(21): p. 4645-4652.
30. Zhang, B., et al., microRNAs as oncogenes and tumor suppressors. Developmental biology, 2007. 302(1): p. 1-12.
31. Jovanovic, M. and M. Hengartner, miRNAs and apoptosis: RNAs to die for. Oncogene, 2006. 25(46): p. 6176-6187.
32. Wang, Y. and C.G. Lee, MicroRNA and cancer--focus on apoptosis. J Cell Mol Med, 2009. 13(1): p. 12-23.
33. Murakami, Y., et al., Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene, 2005. 25(17): p. 2537-2545.
34. Ladeiro, Y., et al., MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 2008. 47(6): p. 1955-1963.
35. Mott, J.L., MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia. Hepatology, 2009. 50(2): p. 630-637.
36. Gramantieri, L., et al., MicroRNA involvement in hepatocellular carcinoma. Journal of cellular and molecular medicine, 2008. 12(6A): p. 2189-2204.
37. Hou, J., et al., Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer cell, 2011. 19(2): p. 232-243.
38. Fulda, S. and K. Debatin, Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 2006. 25(34): p. 4798-4811.
39. Tang, F., et al., RNA-Seq analysis to capture the transcriptome landscape of a single cell. Nature protocols, 2010. 5(3): p. 516-535.
40. Martin, M., Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. journal, 2011. 17(1): p. pp. 10-12.
41. Gardner1, P.P., et al., Rfam: Wikipedia, clans and the “decimal” release. Nucleic Acids Research, 2011. doi: 10.1093/nar/gkq1129.
42. Chan, P.P. and T.M. Lowe, GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Research, 2009. 37(suppl 1): p. D93-D97.
43. Langmead, B., et al., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol, 2009. 10(3): p. R25.
44. Jurka, J., et al., Repbase Update, a database of eukaryotic repetitive elements. Cytogenetic and genome research, 2005. 110(1-4): p. 462-467.
45. Griffiths-Jones, S., et al., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research, 2006. 34(suppl 1): p. D140-D144.
46. Huang da, W., B.T. Sherman, and R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 2009. 4(1): p. 44-57.
47. Trapnell, C., et al., Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature biotechnology, 2010. 28(5): p. 511-515.
48. Chen, Y., et al., Antcin A, a steroid-like compound from Antrodia camphorata, exerts anti-inflammatory effect via mimicking glucocorticoids. Acta Pharmacologica Sinica, 2011. 32(7): p. 904-911.
49. Lee, E.R., et al., Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 2006. 1763(9): p. 958-968.
50. Roy, S.K., R.K. Srivastava, and S. Shankar, Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. Journal of molecular signaling, 2010. 5(1): p. 10.
51. Kumar, A., A. Busca, and M. Saxena, PI3K/Akt pathway contributes to development of apoptosis resistance during differentiation of human macrophages by maintaining antiapoptotic Bcl-xL protein expression. The Journal of Immunology, 2012. 188(48.7).
|